Your Messages Inbox
Your Article Summary
See Latest ArticlesCovidien Reports Third-Quarter 2009 Results
Covidien, 07/31/09
Covidien plc reported results for the third quarter of fiscal 2009. Third–quarter net sales declined 3% to $2.5 billion from $2.6 billion a year ago, with unfavorable foreign exchange of $143 million reducing the quarterly sales growth rate by approximately 5 percentage points. Operational growth, which excludes the impact of foreign exchange, was 2%, driven primarily by higher volume and new products.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 12/07/09
Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09
Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Taro Pharmaceuticals USA, 12/03/09
Article Search
Sponsor